NUVB Nuvation Bio: Bozor kapitallashuvining balans qiymatiga nisbati

Nuvation Bio Inc. (NUVB) - korporativ logo

Nuvation Bio Inc. (NUVB) narxining evolyutsiyasi strategiyasi antitumor agentlarning klinik sinovlariga va xatarlarni kamaytirish uchun tayyor tijorat mahsulotlarini sotib olishga asoslangan aktiv dinamikasini namoyish etmoqda. Joriy ko'rsatkich 6.25 hisoblanadi. Biznes og'ir patologiyalarni davolovchi patentlar orqali uzoq muddatli daromad generatorini yaratish uchun poydevorga asos solmoqda. Ilmiy hamjamiyatdagi yuqori nufuz ularning kichik molekulalarining murakkab neoplazmalarga qarshi salohiyatini tasdiqlaydi.

NUVB - Nuvation Bio Inc. Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022 - 28.10.2026 oraligʻida
Nuvation Pharma brendining mahsuloti

Ushbu koeffitsient biznesning bozor qiymati va uning sof aktivlari o'rtasidagi farqni o'lchaydi, bu esa investorga aksiyalar moliyaviy hisobotlarga nisbatan qanchalik hadda haddan tashqari sotib olinganligini bildiradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatidagi tendentsiyasini tahlil qilish orqali Nuvation Bio Inc. (NUVB) kompaniyasining spekulyativ premiumini baholash mumkin, bu esa yirik ishlab chiqarish korxonalariga ega bo'lmagan va deklarativ ekologik siyosatni yuritayotgan biotexnologiya firmasi uchun asosan klinik sinovlardan kutilayotgan natijalarga asoslanadi.

Toʻgʻridan-toʻgʻri raqobatchilar

Incyte Corporation (INCY) - Bozor kapitallashuvining balans qiymatiga nisbati|hutch-med.com (HCM) - Bozor qiymatining balans qiymatiga nisbati|Day One Biopharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Monopar Therapeutics Inc|Inhibrx Biosciences Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti IMAB (i-mabbiopharma.com)|FENC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Heron HRTX|NVCT (Nuvectis Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|CHRS: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Corbus Pharma CRBP|Cardiff Oncology (CRDF) - Balans qiymatiga nisbatan bozor qiymati|BYSI (BeyondSpring Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BCAB|Bozor qiymatining balans qiymatiga nisbati Lixte Biotechnology Holdings, Inc. (LIXT)|Bozor qiymatining balans qiymatiga nisbati citiuspharma.com CTXR|Kapitallashuvning sof aktivlarga nisbati Cellectar|BioLineRx Corporation - Balans qiymatiga nisbatan bozor qiymati|CANF (Can-Fite BioPharma) - Bozor qiymatining balans qiymatiga nisbati|APRE: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati kaziatherapeutics.com|Silexion Therapeutics (SLXN) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NCNA|Kapitallashuvning sof aktivlarga nisbati CMRX|Cyclacel Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti GTHX (g1therapeutics.com)|Bozor qiymatining balans qiymatiga nisbati Kronos Bio KRON|Kintara Therapeutics Inc - Bozor qiymatining balans qiymatiga nisbati|ONCT (Oncternal) - Bozor qiymatining balans qiymatiga nisbati|PRTG - Bozor qiymatining balans qiymatiga koeffitsiyenti